Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 878739-06-1 Chemical Structure| 878739-06-1

Structure of AZ 628
CAS No.: 878739-06-1

Chemical Structure| 878739-06-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AZ 628 is a pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 105 nM, 34 nM and 29 nM, also inhibits VEGFR2, DDR2, Lyn, Flt1, FMS, etc.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AZ 628

CAS No. :878739-06-1
Formula : C27H25N5O2
M.W : 451.52
SMILES Code : O=C(NC1=CC=C(C)C(NC2=CC3=C(N=CN(C)C3=O)C=C2)=C1)C4=CC=CC(C(C)(C#N)C)=C4
MDL No. :MFCD17392577

Safety of AZ 628

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H319-H335
Precautionary Statements:P261-P301+P310-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Related Pathways of AZ 628

MAPK

Isoform Comparison

Biological Activity

Target
  • B-Raf

    B-Raf, IC50:105 nM

    B-Raf (V600E), IC50:34 nM

  • C-Raf/Raf-1

    C-Raf-1, IC50:29 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
chondrocytes 2 µM AZ-628 inhibited RIP3-mediated OA pathogenesis, reducing the expression of μMP3, μMP13, and COX2. PMC7677493
M14 cells 2 μM five weeks To study the mechanism of AZ628 resistance, it was found that M14 cells developed resistance after continuous exposure to AZ628, and the resistant clones showed a significant increase in IC50 value for AZ628. PMC2692356
A375P 10 nM 72 hours To assess the effect of AZ628 on A375P cell viability, results showed that AZ628 significantly reduced cell viability to 48.8% at 10 nM PMC11593403
A375P 50 nM 72 hours To assess the effect of AZ628 on A375P cell viability, results showed that AZ628 further reduced cell viability to 32.3% at 50 nM PMC11593403
FO-1P 10 nM 72 hours To assess the effect of AZ628 on FO-1P cell viability, results showed that AZ628 significantly reduced cell viability to 46.7% at 10 nM PMC11593403
FO-1P 50 nM 72 hours To assess the effect of AZ628 on FO-1P cell viability, results showed that AZ628 further reduced cell viability to 25.7% at 50 nM PMC11593403
H460/MX20 3 μM 72 hours AZ-628 significantly reversed ABCG2-mediated multidrug resistance, increased intracellular accumulation of ABCG2 substrate drugs, and stimulated ABCG2-associated ATPase activity. PMC7753047
S1-M1-80 3 μM 72 hours AZ-628 significantly reversed ABCG2-mediated multidrug resistance, increased intracellular accumulation of ABCG2 substrate drugs, and stimulated ABCG2-associated ATPase activity. PMC7753047

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.21mL

0.44mL

0.22mL

11.07mL

2.21mL

1.11mL

22.15mL

4.43mL

2.21mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories